Clinical
Trials
- Tislelizumab in MSI-H or dMMR Solid TumorsCondition:Advanced solid tumorsMolecule:Tislelizumab
- Pamiparib and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas (PNOC017)Condition:GlioblastomaMolecule:Pamiparib + Temozolomide
- MYPHISMO: MYB and Tislelizumab Against Multiple Oncologies Trial (MYPHISMO)Condition:Molecule:Tislelizumab
- Study of the Safety and Pharmacokinetics of Lifirafenib in Patients With Solid TumorsCondition:Advanced solid tumorsMolecule:Lifirafenib
- Zanubrutinib in Chinese Patients With Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)Condition:LymphomaMolecule:Zanubrutinib
- A Study Comparing Obinutuzumab and Zanubrutinib Versus Obinutuzumab Alone in Treating R/R Follicular LymphomaCondition:LymphomaMolecule:Zanubrutinib
- Zanubrutinib in Combination With Obinutuzumab in Subjects With B-Cell Lymphoid MalignanciesCondition:Lymphoma, Leukemia, MyelomaMolecule:Zanubrutinib
- A Study Comparing Zanubrutinib With Bendamustine Plus Rituximab in Patients With Previously Untreated CLL or SLLCondition:Leukemia, LymphomaMolecule:Zanubrutinib
- A Study Comparing Zanubrutinib and Ibrutinib in Subjects With Waldenström's Macroglobulinemia (WM)Condition:LymphomaMolecule:Zanubrutinib
- Study of Zanubrutinib in Chinese Subjects With Relapsed/Refractory Waldenström's Macroglobulinemia (WM)Condition:LymphomaMolecule:Zanubrutinib
See All Trials
Clinical trials are an important part of our research and development efforts and help make possible access to safe and potentially life-saving treatments.